Joseph Wolk
Directeur Financier/CFO chez JOHNSON & JOHNSON
Fortune : 11 M $ au 30/04/2024
Profil
Joseph J. Wolk occupe le poste de directeur financier et vice-président exécutif chez Johnson & Johnson. M. Wolk est également membre du Cnbc Global Cfo Council. M. Wolk est titulaire d'un diplôme de premier cycle de l'université St. Joseph et d'un diplôme d'études supérieures de l'école de droit Beasley de l'université Temple.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
JOHNSON & JOHNSON
0,00% | 15/02/2024 | 70 938 ( 0,00% ) | 10 M $ | 30/04/2024 |
KENVUE, INC.
0,00% | 25/03/2024 | 8 307 ( 0,00% ) | 157 999 $ | 30/04/2024 |
Postes actifs de Joseph Wolk
| Sociétés | Poste | Début |
|---|---|---|
| JOHNSON & JOHNSON | Directeur Financier/CFO | 01/07/2018 |
| KENVUE INC. | Directeur/Membre du Conseil | 08/05/2023 |
Cnbc Global Cfo Council
 Cnbc Global Cfo Council Miscellaneous Commercial ServicesCommercial Services CNBC Global CFO Council operates as a business association of chief financial officers. The private company is based in Chicago. | Corporate Officer/Principal | - |
| Stanford University School of Medicine | Corporate Officer/Principal | - |
Wall Street Journal Cfo Network
 Wall Street Journal Cfo Network Miscellaneous Commercial ServicesCommercial Services The Wall Street Journal CFO Network operates as a membership organization for CFOs. | Corporate Officer/Principal | - |
| St. Joseph's University | Directeur/Membre du Conseil | - |
Anciens postes connus de Joseph Wolk
| Sociétés | Poste | Fin |
|---|---|---|
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Directeur Financier/CFO | 01/01/2016 |
Formation de Joseph Wolk
| St. Joseph's University | Undergraduate Degree |
| Temple University Beasley School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| KENVUE INC. | Consumer Non-Durables |
| Entreprise privées | 3 |
|---|---|
Cnbc Global Cfo Council
Cnbc Global Cfo Council Miscellaneous Commercial ServicesCommercial Services CNBC Global CFO Council operates as a business association of chief financial officers. The private company is based in Chicago. | Commercial Services |
Wall Street Journal Cfo Network
Wall Street Journal Cfo Network Miscellaneous Commercial ServicesCommercial Services The Wall Street Journal CFO Network operates as a membership organization for CFOs. | Commercial Services |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |